Recent Finacing
Recent Raise
Cytochroma is a clinical-stage specialty pharmaceutical company developing vitamin D–based therapies CTA018, CTAP201 and CTAP101 for vitamin D insufficiency, SHPT and hyperphosphatemia in CKD, advancing into mid/late-stage trials.
